Chestnut Hill, MA, United States of America

Steven D Freedman

This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: Beth Israel Deaconess Medical Center, Inc., The Beth Israel Hospital Association. Active years: 1997-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steven D Freedman. Retrieved from https://idiyas.com/inventor/steven-d-freedman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 75.0

Average Co-Inventor Count = 1.6

ph-index = 4

Forward Citations = 170(Granted Patents)


Location History:

  • Brighton, MA (US) (1997 - 2003)
  • Chestnut Hill, MA (US) (2011)

Company Filing History:


Years Active: 1997-2011

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Steven D Freedman: Innovator in Medical Treatments

Introduction

Steven D Freedman is a notable inventor based in Chestnut Hill, MA (US). He has made significant contributions to the field of medicine, particularly in the treatment of diseases associated with genetic mutations. With a total of 4 patents to his name, Freedman has focused on innovative methods that address critical health issues.

Latest Patents

Freedman's latest patents include groundbreaking methods for modulating PPAR biological activity for the treatment of diseases caused by mutations in the CFTR gene. This invention features methods for treating diseases associated with mutations in the CFTR gene by administering PPAR agonists, specifically PPARγ, PPARα, and PPARδ agonists, PPAR inducers, and/or antioxidants. Additionally, he has disclosed screening methods for identifying therapeutically useful candidate compounds. Another significant patent involves methods for treating disorders in which docosahexaenoic acid (DHA) levels are affected. This method includes administering a therapeutically effective amount of DHA to subjects suffering from disorders characterized by a defect in the CF gene, such as cystic fibrosis, or chronic inflammatory disorders like ulcerative colitis, Crohn's disease, chronic pancreatitis, asthma, rheumatoid arthritis, or chronic gastritis. Furthermore, he has developed methods for ameliorating the effects of cystic fibrosis in newborns and increasing surfactant levels in fetuses.

Career Highlights

Throughout his career, Freedman has worked with esteemed institutions such as Beth Israel Deaconess Medical Center, Inc. and The Beth Israel Hospital Association. His work has significantly impacted the medical community, particularly in the areas of genetic disorders and inflammatory diseases.

Collaborations

Freedman has collaborated with notable colleagues, including Juan G Alvarez and Irving Waxman. These partnerships have contributed to the advancement of his research and the development of his innovative patents.

Conclusion

Steven D Freedman is a distinguished inventor whose work in medical treatments has the potential to improve the lives of many individuals suffering from genetic and inflammatory disorders. His innovative approaches and collaborations highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…